Skip to main content
Back to OrbiMed

OrbiMed's Health Care Portfolio

Browse 52 Health Care companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Health Care Companies
52
Total Funding in Health Care
$4.1B

Health Care Portfolio Companies (52)

Export
BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

Health Care

Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.

Rochester, United States
April 2026
Private Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

San Diego, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Watertown, United States
September 2025
$200.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedical Device

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.

Dublin, Ireland
August 2025
$80.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Oakdale, United States
May 2025
$52.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
May 2025
$38.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Watertown, United States
October 2024
$115.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Chicago, United States
July 2024
$45.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedical DeviceTherapeutics

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

San Francisco, United States
January 2024
$40.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareInternetPharmaceutical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Oakland, United States
November 2023
$30.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health CareHome Health CareMachine LearningMedical DevicemHealthSoftwareTelehealth

TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.

New York, United States
August 2023
$49.0M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyData Collection and LabelingHealth CareMedical DeviceWearables

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Boca Raton, United States
December 2025
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareManufacturingTherapeutics

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

San Francisco, United States
December 2025
$70.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

San Diego, United States
December 2025
$84.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical DeviceNeuroscience

Stairway Medical is a developer of implantable brain-computer interface technology.

Pudong, China
March 2026
$72.6M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedical

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Changping, China
March 2026
$72.8M
Series C

Founder Contacts

19,000+ verified contacts

Consumer GoodsFast-Moving Consumer GoodsFitnessHealth CareWellness

Started in 2013, Redcliffe Hygiene Private Limited is India's fastest growing hygiene company.

Gurgaon, India
January 2026
$32.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Palo Alto, United States
January 2026
$200.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Business IntelligenceHealth CareMedical

Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.

New York, United States
December 2025
$200.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Beltsville, United States
November 2025
$21.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Cambridge, United States
October 2025
$155.3M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

New York, United States
September 2025
$17.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Foster City, United States
September 2025
$4.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Forte Biosciences is a biotechnology company that focuses on dermatology.

Sherman Oaks, United States
June 2025
$75.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Cambridge, United States
January 2025
$3.9M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Sandwich, United Kingdom
December 2024
$140.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

Copenhagen, Denmark
November 2024
$135.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post Ipo Secondary

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Lexington, United States
August 2024
$125.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

Tel Aviv, Israel
July 2024
$10.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Dover, United States
July 2024
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Kadima, Israel
July 2024
$105.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio